Shallis RM, Daver NG, Altman JK, Hasserjian RP, et al. TP53-altered acute myeloid leukemia and myelodysplastic syndrome with excess blasts should be approached as a single entity. Cancer 2022 Nov 17. doi: 10.1002/cncr.34535.
PMID: 36397669